Categories: News

Russell Health: ‘Most Promising Bio Tech Startups 2020’

WILLOWBROOK, Ill., Jan. 4, 2021 /PRNewswire/ — Based in Willowbrook, Illinois, Russell Health, a national marketer and distributor of specialty medical products and services has recently been awarded “Most Promising Bio Tech Startups 2020” by Startup City.

About Russell Health: Russell Health and its partners have distributed regenerative therapy products nationwide and achieved profound clinical outcomes in multiple therapeutic areas including cosmetics, wound care, pain management, podiatry, orthopedics, dentistry and gynecology.

With their partners and suppliers, they work to provide innovative life-changing and sustaining products and therapies to patients and healthcare providers around the world. 

Stem Cell Recruitment Therapy® is Russell Health’s revolutionary procedure to help rejuvenate, regenerate and lubricate ailing joints as well as help to increase mobility while decreasing pain. Responsibly sourced acellular tissue allografts are helping people of all ages to recover from injuries and get their life back.

In honor of their achievements, StartUp City has featured an article about the innovators titled: “Russell Health: Bringing Life-Changing Innovation through Regenerative Medicine.” Read the full article here.

Article Quote:

“Jonathan Benstent notes: Regenerative medicine is transforming healthcare innovations that have shown to provide improved patient care and increased quality of life. The cutting-edge and less invasive technologies help the body repair itself through its unique healing capabilities and are a powerful alternative to risk-prone surgeries. When Ryan Salvino, an MBA graduate and an enthusiast in medicine, experienced this revitalizing effect first-hand while working as a sales representative for a regenerative medicine company, and it was nothing less than a miracle. “I saw the before and after effect in patients intimately and it’s incredible how effective, painless, and safe these products are for the treatment of multiple disorders throughout the body,” recalls Salvino. (startupcity.com, 2020)

Client Testimonials: 

“The customer service from the company has been exceptional. Russell Health is easily reachable by phone and always happy to provide guidance as needed.” (Dr. Yula Indeyeva, MD)

“Thank you so much for training each of our departments from our medical staff to front desk to the billing department. I thought I was going to have to do everything BUT you did it for us. The staff loved the training and each department knows exactly what they must do to implement this product.” (Dr. Chris Pellow)

Visit Russell Health online to learn more about Stem Cell Recruitment Therapy®. For media inquiries or to contact the Russell Health team directly. Please visit www.russellhealth.com or email marketing@russellhealth.com.

Contact: Veronica Bennett

Phone: 312-919-1896

Email: marketing@russellhealth.com

Mailing Address: 621 Plainfield Rd., Willowbrook, IL 60527

Online: www.russellhealth.com

Related Files

cropped-RussellHealth-Tagline-FullColor-RGB-300×179.png

pp540_3003008541984.jpg

Related Images

russell-health-most-promising.png
Russell Health – Most Promising BioTech Startups 2020
Startup City – Most Promising BioTech Startup of 2020 – Russell Health – Ryan Salvino

Related Links

Stem Cell Recruitment Therapy® – Info

Stem Cell Recruitment Therapy® – Explainer Video

View original content to download multimedia:http://www.prnewswire.com/news-releases/russell-health-most-promising-bio-tech-startups-2020-301200383.html

SOURCE Russell Health

Staff

Recent Posts

Health Care AI Initiative Launched by Paragon Health Institute

New initiative will promote AI policies and solutions to transform American health careWASHINGTON, Jan. 12,…

14 minutes ago

Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound

Agreement expands Amphastar's proprietary peptide pipeline into broader inflammatory and autoimmune conditions RANCHO CUCAMONGA, CA…

14 minutes ago

CelLBxHealth PLC Announces Board Changes

GUILDFORD, SURREY / ACCESS Newswire / January 12, 2026 / CelLBxHealth plc (AIM:CLBX), a leader…

3 hours ago

Cosmo Enters Scale Up Phase with 104M Revenue, 128M Cash, and Breakout AI and Dermatology Platforms

Ad hoc announcement pursuant to Art. 53 LR 2025 marks a key execution year in…

4 hours ago

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

18 hours ago